Psilocybin molecule:

Image from PubChem

Psilocybin Clinical Trials

Randomized Double Blind Placebo Controlled Assessing the Efficacy of Micro-dosed Psilocybin in Reducing Anxiety and or Depression Levels in Adults

To see complete record on, please visit this link

Id: NCT04989972

Organisation Name: Wake Network, Inc.

Overal Status: Withdrawn

Start Date: September 15, 2022

Last Update: June 30, 2022

Lead Sponsor: Wake Network, Inc.

Brief Summary: To investigate the efficacy of a 16 week treatment with PSIL428 patient reported anxiety levels in otherwise healthy individuals suffering from depression and or anxiety symptoms.

  • Anxiety and Depression

Total execution time in seconds: 0.20098304748535